2020
DOI: 10.1016/j.diabet.2019.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Association of C-peptide with diabetic vascular complications in type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
25
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 34 publications
2
25
0
2
Order By: Relevance
“…The questionnaire about demographics, medical history, family history, and lifestyle factors was filled out by the same trained personnel in the SPECT-China study [18,19] during the interview. Clinical examinations, including height, weight, and blood pressure, were measured according to a standard protocol as before [20,21]. Body mass index (BMI) was calculated as the weight in kilograms divided by the height in meters squared.…”
Section: Measurementsmentioning
confidence: 99%
“…The questionnaire about demographics, medical history, family history, and lifestyle factors was filled out by the same trained personnel in the SPECT-China study [18,19] during the interview. Clinical examinations, including height, weight, and blood pressure, were measured according to a standard protocol as before [20,21]. Body mass index (BMI) was calculated as the weight in kilograms divided by the height in meters squared.…”
Section: Measurementsmentioning
confidence: 99%
“…In T2DM, elevated fasting C‐peptide (FCP) levels >2.00 nmol/L indicate the presence of insulin insensitivity (resistance) that is often associated with a higher body mass index (BMI), requiring a higher dose to achieve target levels of HbA1c . Recent findings also confirm a positive association of high C‐peptide levels with the prevalence of cardiovascular disease and an inverse association with progression of diabetic retinopathy . By contrast, low FCP levels (<0.40 nmol/L) indicate a condition of advanced insulin deficiency in T2DM, and are predictive of a poor glycaemic response to insulin secretagogues including glucagon‐like peptide‐1 (GLP‐1) receptor agonists …”
Section: Introductionmentioning
confidence: 88%
“…6,7 Recent findings also confirm a positive association of high C-peptide levels with the prevalence of cardiovascular disease and an inverse association with progression of diabetic retinopathy. 8,9 By contrast, low FCP levels (<0.40 nmol/L) indicate a condition of advanced insulin deficiency in T2DM, and are predictive of a poor glycaemic response to insulin secretagogues including glucagon-like peptide-1 (GLP-1) receptor agonists. 10 Current clinical practice guidelines for T2DM recommend a selective and stepwise approach to therapies, which primarily follows HbA1c values and the presence of concomitant cardiovascular disease.…”
Section: Introductionmentioning
confidence: 99%
“…A population-based study named the METAL study (Environmental Pollutant Exposure and Metabolic Diseases in Shanghai, ChiCTR1800017573, www.chictr.org.cn) was conducted in 2018 (15). Participants were randomly enrolled from seven communities in Huangpu and Pudong District, Shanghai, China and were randomly selected from half of the type 2 diabetic patients in the registration platform of each community healthcare center.…”
Section: Study Design and Participantsmentioning
confidence: 99%